"World-class physicians, state-of-the-art treatment technology and the region?s most robust oncology clinical trials program offer cancer patients in our region the most promising approaches to cancer diagnosis and treatment. But what makes the Center special isn?t limited to new technology. Upon entering, one aspect is very clear?the comfort , care and well-being of patients and caregivers is the number one priority of our physicans and staff at the Singletary Oncology Center."

During the past decade, Lewis Hall Singletary Oncology Center conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 7 clinical trials were completed, i.e. on average, 31.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lewis Hall Singletary Oncology Center" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Bayer" with 1 trials sponsored and "BioNTech SE" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lewis Hall Singletary Oncology Center" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Lewis Hall Singletary Oncology Center" are "Recurrent Breast Carcinoma" (3 trials), "Colorectal Cancer" (2 trials), "Metastatic Breast Carcinoma" (2 trials), "Metastatic Malignant Neoplasm in the Brain" (2 trials) and "Non-Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Lewis Hall Singletary Oncology Center" in a lesser frequency.

Most popular intervention types in "Lewis Hall Singletary Oncology Center" are "Drug" (21 trials), "Biological" (11 trials), "Other" (10 trials), "Procedure" (6 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (8 trials), "Carboplatin" (5 trials), "Cisplatin" (5 trials), "Docetaxel" (4 trials) and "Paclitaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Lewis Hall Singletary Oncology Center" are 23 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Lewis Hall Singletary Oncology Center". undefined are not yet recruiting, 8 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Lewis Hall Singletary Oncology Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Lewis Hall Singletary Oncology Center, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".